cardiomyocyte therapy (BlueRock Therapeutics)

N/A

Report date: 2025/03/17 09:44:34

Base Information

Drug Namecardiomyocyte therapy (BlueRock Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Cardiac myocyte stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBluerock Therapeutics Lp
China Registration ClassN/A

Develop Information

Active CompaniesBluerock Therapeutics Lp
Inactive CompaniesN/A
Active IndicationsMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A